| Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada H Samji, A Cescon, RS Hogg, SP Modur, KN Althoff, K Buchacz, ... PloS one 8 (12), e81355, 2013 | 1687 | 2013 |
| Mental health impacts of the COVID‐19 pandemic on children and youth–a systematic review H Samji, J Wu, A Ladak, C Vossen, E Stewart, N Dove, D Long, G Snell Child and adolescent mental health 27 (2), 173-189, 2022 | 937 | 2022 |
| Climate anxiety in young people: a call to action J Wu, G Snell, H Samji The Lancet Planetary Health 4 (10), e435-e436, 2020 | 310 | 2020 |
| The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study B Nosyk, JSG Montaner, G Colley, VD Lima, K Chan, K Heath, B Yip, ... The Lancet infectious diseases 14 (1), 40-49, 2014 | 272 | 2014 |
| North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in … H Samji, A Cescon, RS Hogg, SP Modur, KN Althoff, K Buchacz, ... PLoS One 8 (12), e81355, 2013 | 237 | 2013 |
| Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 213 | 2014 |
| Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000–2010 K Buchacz, B Lau, Y Jing, R Bosch, AG Abraham, MJ Gill, MJ Silverberg, ... The Journal of infectious diseases 214 (6), 862-872, 2016 | 194 | 2016 |
| Multimorbidity among persons living with human immunodeficiency virus in the United States C Wong, SJ Gange, RD Moore, AC Justice, K Buchacz, AG Abraham, ... Clinical Infectious Diseases 66 (8), 1230-1238, 2018 | 192 | 2018 |
| Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada S Patterson, A Cescon, H Samji, K Chan, W Zhang, J Raboud, ... BMC infectious diseases 15, 1-10, 2015 | 185 | 2015 |
| The continuum of HIV care in rural communities in the United States and Canada: what is known and future research directions KR Schafer, H Albrecht, R Dillingham, RS Hogg, D Jaworsky, K Kasper, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 75 (1), 35-44, 2017 | 152 | 2017 |
| Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy A Trickey, MT May, J Vehreschild, N Obel, MJ Gill, H Crane, C Boesecke, ... PloS one 11 (8), e0160460, 2016 | 142 | 2016 |
| The population level cascade of care for hepatitis C in British Columbia, Canada: the BC Hepatitis Testers Cohort (BC-HTC) NZ Janjua, M Kuo, A Yu, M Alvarez, S Wong, D Cook, J Wong, J Grebely, ... EBioMedicine 12, 189-195, 2016 | 130 | 2016 |
| Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras MB Klein, KN Althoff, Y Jing, B Lau, M Kitahata, V Lo Re III, GD Kirk, ... Clinical Infectious Diseases 63 (9), 1160-1167, 2016 | 117 | 2016 |
| Impact of age on retention in care and viral suppression BR Yehia, P Rebeiro, KN Althoff, AL Agwu, MA Horberg, H Samji, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (4), 413-419, 2015 | 117 | 2015 |
| Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012 O Eyawo, C Franco-Villalobos, MW Hull, A Nohpal, H Samji, P Sereda, ... BMC infectious diseases 17, 1-15, 2017 | 114 | 2017 |
| Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001–2009 DB Hanna, K Buchacz, KA Gebo, NA Hessol, MA Horberg, LP Jacobson, ... Clinical Infectious Diseases 56 (8), 1174-1182, 2013 | 109 | 2013 |
| Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada NZ Janjua, M Chong, M Kuo, R Woods, J Wong, EM Yoshida, M Sherman, ... Journal of hepatology 66 (3), 504-513, 2017 | 105 | 2017 |
| Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009 Antiretroviral Therapy Cohort Collaboration (ART-CC Aids 27 (5), 803-813, 2013 | 104 | 2013 |
| Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets NZ Janjua, N Islam, M Kuo, A Yu, S Wong, ZA Butt, M Gilbert, J Buxton, ... International Journal of Drug Policy 55, 31-39, 2018 | 97 | 2018 |
| Mortality according to CD4 count at start of combination antiretroviral therapy among HIV-infected patients followed for up to 15 years after start of treatment: collaborative … MT May, JJ Vehreschild, A Trickey, N Obel, P Reiss, F Bonnet, ... Clinical Infectious Diseases 62 (12), 1571-1577, 2016 | 90 | 2016 |
